Community Practice Connections: 2nd Annual School of Gastrointestinal Oncology (SOGO)
WebcastFaculty
OVERVIEW
Community Practice Connections: 2nd Annual School of Gastrointestinal Oncology (SOGO) is organized by Physicians Education Resource, LLC (PER) and will be held during Jun 30, 2017 - Jun 30, 2018.
The target audience for this medical event is is directed toward oncologists, surgeons, and radiologists involved in the treatment of GI cancers. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals involved in the treatment of GI cancers may also participate. This CME Conference has been approved for a maximum of 1.5 AMA PRA Category 1 Credits.
Conference Objectives :
At the conclusion of this activity, you should be better prepared to:
• Explain prognostic and predictive markers, and how they can be used to stratify risk and inform clinical decision making in the management of gastrointestinal (GI) malignancies
• Apply pivotal trial evidence in the personalized management of advanced forms of GI tumors
• Outline multidisciplinary methods to proactively plan for, prevent, and mitigate treatment-related toxicities
• Detail the most clinically relevant clinical trial findings concerning emerging strategies to manage GI malignancies
• Apply emerging clinical trial data to manage cases in the context of evolving treatment paradigms for GI tumors
Additional details will be posted as soon as they are available.
The target audience for this medical event is is directed toward oncologists, surgeons, and radiologists involved in the treatment of GI cancers. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals involved in the treatment of GI cancers may also participate. This CME Conference has been approved for a maximum of 1.5 AMA PRA Category 1 Credits.
Conference Objectives :
At the conclusion of this activity, you should be better prepared to:
• Explain prognostic and predictive markers, and how they can be used to stratify risk and inform clinical decision making in the management of gastrointestinal (GI) malignancies
• Apply pivotal trial evidence in the personalized management of advanced forms of GI tumors
• Outline multidisciplinary methods to proactively plan for, prevent, and mitigate treatment-related toxicities
• Detail the most clinically relevant clinical trial findings concerning emerging strategies to manage GI malignancies
• Apply emerging clinical trial data to manage cases in the context of evolving treatment paradigms for GI tumors
Additional details will be posted as soon as they are available.
SPECIALITIES
OncologyGastroenterology
Quick Links